NO20030073L - Medikamentleveringssystem for medikamenter som er lite vannopplöselige - Google Patents

Medikamentleveringssystem for medikamenter som er lite vannopplöselige

Info

Publication number
NO20030073L
NO20030073L NO20030073A NO20030073A NO20030073L NO 20030073 L NO20030073 L NO 20030073L NO 20030073 A NO20030073 A NO 20030073A NO 20030073 A NO20030073 A NO 20030073A NO 20030073 L NO20030073 L NO 20030073L
Authority
NO
Norway
Prior art keywords
water soluble
drugs
delivery system
drug delivery
hydrogels
Prior art date
Application number
NO20030073A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030073D0 (no
Inventor
Esteban Chornet
Claudia Ishizawa
Severian Dumitriu
Original Assignee
Kemestrie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kemestrie Inc filed Critical Kemestrie Inc
Publication of NO20030073D0 publication Critical patent/NO20030073D0/no
Publication of NO20030073L publication Critical patent/NO20030073L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Colloid Chemistry (AREA)
NO20030073A 2000-07-07 2003-01-07 Medikamentleveringssystem for medikamenter som er lite vannopplöselige NO20030073L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21662700P 2000-07-07 2000-07-07
US25238900P 2000-11-21 2000-11-21
PCT/CA2001/000993 WO2002003962A2 (en) 2000-07-07 2001-07-06 Drug delivery system for poorly water soluble drugs

Publications (2)

Publication Number Publication Date
NO20030073D0 NO20030073D0 (no) 2003-01-07
NO20030073L true NO20030073L (no) 2003-03-06

Family

ID=26911183

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030073A NO20030073L (no) 2000-07-07 2003-01-07 Medikamentleveringssystem for medikamenter som er lite vannopplöselige

Country Status (12)

Country Link
US (1) US20030157171A1 (de)
EP (1) EP1299089B1 (de)
JP (1) JP2004502722A (de)
AT (1) ATE322891T1 (de)
AU (1) AU2001272262A1 (de)
BR (1) BR0112258A (de)
CA (1) CA2415081A1 (de)
DE (1) DE60118742D1 (de)
IL (1) IL153814A0 (de)
NO (1) NO20030073L (de)
NZ (1) NZ523418A (de)
WO (1) WO2002003962A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005062041A1 (en) * 2003-12-24 2005-07-07 Astrazeneca Ab Pharmaceutical dissolution testing using a non-ionic surfactant
IL160095A0 (en) * 2004-01-28 2004-06-20 Yissum Res Dev Co Formulations for poorly soluble drugs
ES2545589T3 (es) * 2005-04-08 2015-09-14 Abbott Laboratories Formulaciones farmacéuticas orales que comprenden sales de ácido fenofíbrico
JP2009511435A (ja) * 2005-09-28 2009-03-19 ディーエヌピー・カナダ・インコーポレーテッド 高脂血症の予防および治療のためのポリキトサミンとフィブレートの組み合わせ
CN101299993A (zh) * 2005-11-04 2008-11-05 伊士曼化工公司 用于给药难溶的药学活性剂的羧烷基纤维素酯
US8088832B2 (en) 2006-04-05 2012-01-03 Woodland Biofuels Inc. System and method for converting biomass to ethanol via syngas
US20100129423A1 (en) * 2007-04-19 2010-05-27 Medovent Gmbh Device made at least partially of n-acetylchitosan with controlled biodissolution
US9636309B2 (en) 2010-09-09 2017-05-02 Micell Technologies, Inc. Macrolide dosage forms
AU2012291631A1 (en) 2011-08-01 2014-02-27 Sun Pharmaceutical Industries Limited Dissolution enhanced controlled drug delivery system for poorly water soluble drugs
CN103315960A (zh) * 2012-03-19 2013-09-25 胡容峰 基于球晶技术固体自微乳及其制备方法
US20200262937A1 (en) * 2017-09-27 2020-08-20 Association For The Advancement Of Tissue Engineering Cell Based Technologies & Therapies (A4Tec)- High molecular weight chitosan, process for obtaining and uses thereof
KR102407470B1 (ko) * 2021-08-09 2022-06-10 인제대학교 산학협력단 하이드로겔에 담지된 약물의 방출량 검출 방법
CN114515268B (zh) * 2022-02-21 2024-06-21 上海宣泰医药科技股份有限公司 熊去氧胆酸药物组合物及其制备方法和药物制剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620706A (en) * 1995-04-10 1997-04-15 Universite De Sherbrooke Polyionic insoluble hydrogels comprising xanthan and chitosan
CA2243619A1 (fr) * 1998-07-17 2000-01-17 Universite De Sherbrooke Hydrogels polyioniques a base de xanthane et chitosane pour stabilisation et relargage controle des vitamines

Also Published As

Publication number Publication date
US20030157171A1 (en) 2003-08-21
EP1299089B1 (de) 2006-04-12
AU2001272262A1 (en) 2002-01-21
EP1299089A2 (de) 2003-04-09
JP2004502722A (ja) 2004-01-29
DE60118742D1 (de) 2006-05-24
WO2002003962A3 (en) 2002-06-13
IL153814A0 (en) 2003-07-31
CA2415081A1 (en) 2002-01-17
WO2002003962A2 (en) 2002-01-17
ATE322891T1 (de) 2006-04-15
NZ523418A (en) 2004-09-24
BR0112258A (pt) 2003-06-24
NO20030073D0 (no) 2003-01-07

Similar Documents

Publication Publication Date Title
NO20030073L (no) Medikamentleveringssystem for medikamenter som er lite vannopplöselige
NO20042816L (no) Fremgangsmater for maling av kraften av glatirameracetat
MXPA03006093A (es) Derivados de n(fenilsulfonil)glicina y su uso terapeutico.
MY125978A (en) Admantane derivatives
MXPA03007837A (es) Composiciones para suministrar bisfosfonatos.
FR16C0030I1 (fr) Glycoproteine d'hyaluronidase soluble (shasegp), son procede de preparation, utilisations et compositions pharmaceutiques le comportant
HK1046527A1 (zh) 金剛烷衍生物
MXPA02011458A (es) Derivados de acilfenilurea, metodos para su produccion y uso de los mismos como farmacos.
ATE389385T1 (de) Ophthalmische depot-formulierungen zur periokkularen oder subkonjunktivalen verabreichung
MXPA02009275A (es) Metodo para preparar dispersiones de alta presion/alto esfuerzo cortante que contienen ingredientes fisiologicamente activos.
PL364598A1 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
NO20014101L (no) Stabilisert oral farmasöytisk blanding inneholdende iodid og iodat og fremgangsmåte
WO2004050057A3 (en) An exopolysaccharides delivery system for active molecules
DE69924004D1 (de) Verabreichungssystem für wasserunlösliche arzneistoffe
EA200400455A1 (ru) Способ приготовления быстрорастворимой дозировочной формы
TW200501965A (en) Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle
MY134167A (en) Biphenylcarboxamides useful as lipid lowering agents
ES2189354T3 (es) Procedimiento para la preparacion de furoato mometasona.
MXPA05008902A (es) Soluciones de drogas en mentol.
CY1111960T1 (el) Νεα φαρμακευτικα παρασκευασματα καθως επισης μεθοδος για την παρασκευη αυτων
AU2003256882A1 (en) Methods of drug delivery using sulphated chitinous polymers
AU2001258754A1 (en) Aqueous liquid preparation
AU7599900A (en) Formulations of paclitaxel entrapped into nanoparticles of polymeric micelles
MXPA05009428A (es) Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas.
SG153663A1 (en) Process for the production of biodegradable, functionalised polymer particles and use thereof as pharmaceutical supports

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application